Workshop on Polio updates End game strategies Organized

  • Slides: 58
Download presentation
Workshop on “Polio updates & End game strategies” Organized by Community Medicine Department, GMERS

Workshop on “Polio updates & End game strategies” Organized by Community Medicine Department, GMERS Medical College, Sola, in collaboration with NPSP (WHO), Gandhinagar 16 th April, 2013 National Polio Surveillance Project: Go. I & WHO

Polio update, AFP Surveillance End game strategy Dr. Anish Sinha State Surveillance Medical Officer

Polio update, AFP Surveillance End game strategy Dr. Anish Sinha State Surveillance Medical Officer World Health Organization National Polio Surveillance Project, India, Gandhinagar. National Polio Surveillance Project: Go. I & WHO

Contents…. • • • Global/ National / State update. Epidemiology of polio. AFP Surveillance.

Contents…. • • • Global/ National / State update. Epidemiology of polio. AFP Surveillance. SIAs (NIDs / SNIDs). Certification of Polio eradication. End game strategy. National Polio Surveillance Project: Go. I & WHO

Areas with Active Polio Transmission 1988 350 000 cases 125 countries 2012 223 cases

Areas with Active Polio Transmission 1988 350 000 cases 125 countries 2012 223 cases 5 countries National Polio Surveillance Project: Go. I & WHO

Rukhsar Khatoon last case of WPV detected in India (Jan 2011), her mother Shabida

Rukhsar Khatoon last case of WPV detected in India (Jan 2011), her mother Shabida Bibi in Shahapar village, WB National Polio Surveillance Project: Go. I & WHO

India • India last polio case on 13 th Jan. 2011 • Removed from

India • India last polio case on 13 th Jan. 2011 • Removed from list of ENDEMIC Countries list in Feb. 2012 Looking forward for Certification (SEAR) in Feb. 2014 National Polio Surveillance Project: Go. I & WHO

Global Polio updates 2012 Nigeria (122) Pakistan (58) ONLY THREE ENDEMIC COUNTRIES Afghanistan (37)

Global Polio updates 2012 Nigeria (122) Pakistan (58) ONLY THREE ENDEMIC COUNTRIES Afghanistan (37) CHAD 5 WPV 1 (IMPORTATION) Niger 1 WPV 1 Till 9 Apr 13 – 18 cases (Nig-11, Pak-6, Afg-1) National Polio Surveillance Project: Go. I & WHO

WPV transmission from Northern Sindh, Pakistan to Greater Cairo (environmental sample +ve), Egypt Importation

WPV transmission from Northern Sindh, Pakistan to Greater Cairo (environmental sample +ve), Egypt Importation of WPV 2013 -, Egypt - polio free since 2004. National Polio Surveillance Project: Go. I & WHO

WPV cases, India 1934 No case since Jan 2011 1600 P 1 wild *

WPV cases, India 1934 No case since Jan 2011 1600 P 1 wild * data as on 12 April 2013 P 2 wild P 3 wild National Polio Surveillance Project: Go. I & WHO

Location of wild poliovirus and VDPV cases by type, India 2011 * data as

Location of wild poliovirus and VDPV cases by type, India 2011 * data as on 12 April 2013 2012 2013* National Polio Surveillance Project: Go. I & WHO

Last wild poliovirus cases by type, India WPV 2 24/10/1999 Aligarh (UP) WPV 3

Last wild poliovirus cases by type, India WPV 2 24/10/1999 Aligarh (UP) WPV 3 22/10/2010 Pakur (JH) WPV 1 13/01/2011 Howrah (WB) * data as on 12 April 2013 National Polio Surveillance Project: Go. I & WHO

Wild poliovirus detected in sewage samples, 2010 – 2011 2010 Mumbai Delhi 2011 Mumbai

Wild poliovirus detected in sewage samples, 2010 – 2011 2010 Mumbai Delhi 2011 Mumbai Delhi Patna Kolkata Wild poliovirus type 1 Wild poliovirus type 3 Negative for wild poliovirus X Sampling not scheduled Scheduled but sample Surveillance not collected National Polio Project: Go. I & WHO

Wild poliovirus detected in sewage samples, 2012* Mumbai Delhi Patna Kolkata * data as

Wild poliovirus detected in sewage samples, 2012* Mumbai Delhi Patna Kolkata * data as on 12 April 2013 Wild poliovirus type 1 Negative for wild poliovirus Wild poliovirus type 3 Result pending X Scheduled but sample not collected Sampling not scheduled National Polio Surveillance Project: Go. I & WHO

Wild poliovirus detected in sewage samples, 2013* Mumbai Delhi Patna Kolkata * data as

Wild poliovirus detected in sewage samples, 2013* Mumbai Delhi Patna Kolkata * data as on 12 April 2013 Wild poliovirus type 1 Negative for wild poliovirus Wild poliovirus type 3 Result pending X Scheduled but sample not collected Sampling not scheduled National Polio Surveillance Project: Go. I & WHO

Progress in India–A snapshot 1934 1600 P 1 wild * data as on 12

Progress in India–A snapshot 1934 1600 P 1 wild * data as on 12 April 2013 • 1995: Polio SIAs (campaigns) launched • 1997: Acute Flaccid Paralysis (AFP) Surveillance initiated • 1999: Last case of Wild Polio Virus (WPV) type 2 – (U. P) • 2010: Last case of WPV type 3 - (Jharkhand) • 2011: Last case of WPV type 1 - ( West Bengal) • 2012: India removed from list of endemic countries P 2 wild P 3 wild National Polio Surveillance Project: Go. I & WHO

Gujarat Wild Cases 2000 -13 Year - Cases BAN 2000 - 2 2001 -

Gujarat Wild Cases 2000 -13 Year - Cases BAN 2000 - 2 2001 - 1 PAT KTC 2002 - 24 2003 - 3 RJT SRN AND JMD 2005 - 1 2007 - 1 2008 - 0 2009 - 0 2010 - 0 2011 - 0 2012 - 0 2013 - 0 JMC BVC RJC POR AML JUN PML GNR AMC KDA AMD 2004 - 0 2006 - 4 SBK MSN BVN DHD VDC VDD BRH NMD SRC SRT NAV DNG VLD National Polio Surveillance Project: Go. I & WHO

Epidemiology of Polio National Polio Surveillance Project: Go. I & WHO

Epidemiology of Polio National Polio Surveillance Project: Go. I & WHO

Polio: Epidemiology • Reservoir of infection: Man (for every clinical case, 1000 sub clinical

Polio: Epidemiology • Reservoir of infection: Man (for every clinical case, 1000 sub clinical case (children) & 75 (adults) • Infective material: feces • Period of communicability: most infective 10 days before & after onset. Host factors • Age: 6 months to 3 years most common • Sex: 3: 1 ---male: female • Precipitating factors: fatigue, trauma, I/M injections • Immunity : OPV (life long) Environmental factors • Rainy season (Jun – Sep), overcrowding & poor sanitation National Polio Surveillance Project: Go. I & WHO

Paralytic Poliomyelitis • Acute onset • Fever just prior to onset of paralysis •

Paralytic Poliomyelitis • Acute onset • Fever just prior to onset of paralysis • Associated symptoms: malaise, sore throat, constipation abdominal pain. Muscle pain • Signs of meningeal irritation, stiffness in back & neck may be present. • Progression: maximum in <4 days. starts proximally and moves distally • Involvement: asymmetrical patchy paralysis , proximal muscle groups> distal muscle groups • DTR: diminished • Cranial nerve involvement : uncommon • Respiratory insufficiency: life threatening, uncommon • Sensory: no loss only way to confirm is isolation of wild virus from stool. National Polio Surveillance Project: Go. I & WHO

Strategies of Polio Eradication § 1985 – Routine immunization Individual immunity § 1995 –

Strategies of Polio Eradication § 1985 – Routine immunization Individual immunity § 1995 – NID’s ( PPI / IPPI ) To replace wild with vaccine virus § 1997 - AFP surveillance To identify reservoir of transmission § 2000 – Mopping up immunization To eliminate last foci of transmission National Polio Surveillance Project: Go. I & WHO

AFP Surveillance National Polio Surveillance Project: Go. I & WHO

AFP Surveillance National Polio Surveillance Project: Go. I & WHO

Objective of AFP surveillance Reliably detect areas where polio transmission is occurring or likely

Objective of AFP surveillance Reliably detect areas where polio transmission is occurring or likely to occur National Polio Surveillance Project: Go. I & WHO

Principle of AFP Surveillance in identifying polio cases Identify children with the SYNDROME of

Principle of AFP Surveillance in identifying polio cases Identify children with the SYNDROME of Acute Flaccid Paralysis • Acute- Sudden onset, Rapid progression • Flaccid- Floppy/ soft & yielding to passive stretching at anytime during the illness. • Paralysis is loss of strength of muscles, Severe loss of motor strength is called paralysis or plegia Paresis- less severe loss of motor strength National Polio Surveillance Project: Go. I & WHO

Definition of AFP for surveillance purposes Sudden onset weakness & floppiness in any part

Definition of AFP for surveillance purposes Sudden onset weakness & floppiness in any part of the body in a child < 15 years of age or paralysis in a person of any age in which polio is suspected. National Polio Surveillance Project: Go. I & WHO

Logic of AFP investigation & stool sample collection • Sensitivity increases when all AFP

Logic of AFP investigation & stool sample collection • Sensitivity increases when all AFP cases investigated • Testing of stools of all AFP - most valid test for identification of Polio • ALL cases with ‘AFP’ should be reported & their stools must be tested!! • Even if other ‘tests’ (CT scan, MRI, etc. ) or additional clinical information point to other diagnoses; stools must be tested to rule out Polio National Polio Surveillance Project: Go. I & WHO

Reporting • All AFP cases should be reported immediately • ALL AFP cases reported

Reporting • All AFP cases should be reported immediately • ALL AFP cases reported within 6 months of onset of paralysis should be investigated • All reporting units, informers and other contacts should continue to report AFP cases as per existing case definition National Polio Surveillance Project: Go. I & WHO

Action when AFP is reported • FIRST – Start stool collection process • Investigate

Action when AFP is reported • FIRST – Start stool collection process • Investigate - SMO/ DIO - Confirm if AFP, if not reject case & record the same. There is only one category of cases - AFP • Allot EPID number & Report the case as AFP • CIF & LRF should be filled. • Use the revised CIF/ Linelist form. • Ensure that stools are transported to lab in cold chain • NPSU will Classify after lab result received • Give feedback to the source that the AFP reported was/ was not polio. • Maintain documentation at ALL levels. National Polio Surveillance Project: Go. I & WHO

Therefore… The basic system of AFP surveillance remains unchanged • To enhance sensitivity, all

Therefore… The basic system of AFP surveillance remains unchanged • To enhance sensitivity, all cases of acute flaccid paralysis should be reported & investigated • Borderline cases should be included & stool specimens tested National Polio Surveillance Project: Go. I & WHO

The AFP Surveillance System Hospitals Clinics Community Investigation Non-Polio AFP National Polio Surveillance Project:

The AFP Surveillance System Hospitals Clinics Community Investigation Non-Polio AFP National Polio Surveillance Project: Go. I & WHO

When too much polio is around…. . AFP cases Polio cases Borderline AFP cases

When too much polio is around…. . AFP cases Polio cases Borderline AFP cases Non-AFP cases Surveillance sensitivity is adequate enough to detect 90% polio cases National Polio Surveillance Project: Go. I & WHO

When transmission is very low…. . If borderline cases are taken & stool specimens

When transmission is very low…. . If borderline cases are taken & stool specimens collected … Surveillance sensitivity is not good enough & detects only 50% polio cases …Sensitivity increases and leads to 100% detection of polio cases AFP cases Polio cases Borderline cases Non-AFP cases Remember Non AFP cases still not taken National Polio Surveillance Project: Go. I & WHO

Likely to be AFP cases…. • • GBS of any variety Transverse myelitis Monoparesis

Likely to be AFP cases…. • • GBS of any variety Transverse myelitis Monoparesis Traumatic neuritis Flaccid Paraplegias Flaccid Quadriplegia Isolated bulbar paralysis • Post-diphtheric polyneuritis • Viral neuritis, • Flaccid hemiplegia • Isolated neck paralysis • Wrist/foot drop, etc. • Transient paresis • Facial Palsy. National Polio Surveillance Project: Go. I & WHO

Analysis of initial clinical presentation of WPV 2006 - 10 Clinical Presentation 2006 2007

Analysis of initial clinical presentation of WPV 2006 - 10 Clinical Presentation 2006 2007 2008 2009 2010 586 (86. 7) 757 (86. 71) 494 (88. 37) 648 (87. 45) 32 (76. 19) Only H/O Paralysis 24 (2. 7) 14 (1. 60) 14 (2. 5) 10 (1. 35) 1 (2. 38) Hemiplegia 35 (5. 2) 54 (6. 19) 25 (4. 47) 48 (6. 48) 3 (7. 14) G. B. Syndrome 6 (0. 9) 3 (0. 34) 3 (0. 54) 3 (0. 40) Traumatic Neuritis 4 (0. 6) 8 (0. 92) 1 (0. 18) 2 (0. 27) Only Limp 4 (0. 6) 1 (0. 11) 0 (0) 4 (0. 54) Acute Encephalitis 3 (0. 4) 3 (0. 34) 4 (0. 72) 1 (0. 13) Isolated Facial Palsy 3 (0. 4) 19 (2. 18) 10 (1. 79) 14 (1. 89) Isolated Neck Flop 4 (0. 6) 5 (0. 57) 4 (0. 72) 4 (0. 54) 0 (0) 2 (0. 23) 0 (0) 1 (0. 13) 7 (1. 0) 7 (0. 80) 4 (0. 72) 6 (0. 81) 2 (4. 76) 676 873 559 741 42 Clinical Poliomyelitis Post Diptheric Polyneuritis Others Total 4 (9. 52) National Polio Surveillance Project: Go. I & WHO

STOOL COLLECTION, STORAGE , TRANSPORT. • Adequate Stool. – 2 Specimens, 24 Hours Apart.

STOOL COLLECTION, STORAGE , TRANSPORT. • Adequate Stool. – 2 Specimens, 24 Hours Apart. – 8 gms. – Within 14 Days of Paralysis Onset & with proper Cold Chain • Procedure. – Errors. – Storage(Delayed Second Sample) • Cold Chain. • Rectal Tube. • Transport. (PHN & HA) • Death of AFP Case. ( Spinal Cord , Intestinal Content) National Polio Surveillance Project: Go. I & WHO

GOLD STANDARD FOR AFP SURVEILLANCE • Non – Polio AFP Rate > 2. 0

GOLD STANDARD FOR AFP SURVEILLANCE • Non – Polio AFP Rate > 2. 0 • Adequate Stool Samples > 80% • Timeliness of Reporting > 80% National Polio Surveillance Project: Go. I & WHO

VIROLOGIC CLASSIFICATION SCHEME CONFIRM WILD POLIOVIRUS COMPATIBLE RESIDUAL WEAKNESS, DIED OR LOST TO F/U

VIROLOGIC CLASSIFICATION SCHEME CONFIRM WILD POLIOVIRUS COMPATIBLE RESIDUAL WEAKNESS, DIED OR LOST TO F/U AFP EXPERT REVIEW DISCARD INADEQUATE STOOL SPECIMENS NO RESIDUAL WEAKNESS NO WILD POLIOVIRUS TWO ADEQUATE* DISCARD STOOL SPECIMENS National Polio Surveillance Project: Go. I & WHO

Compatible Cases 2002 -2013 2002 – 14 cases 2003 – 4 cases 2004 –

Compatible Cases 2002 -2013 2002 – 14 cases 2003 – 4 cases 2004 – 1 case 2005 – 7 cases 2006 – 3 cases 2007 – 5 cases 2008 – 1 case 2009 – 1 case 2010 – 1 case 2011 – 0 Case 2012 – 0 Case 2013 – 0 Case National Polio Surveillance Project: Go. I & WHO

HOT CASE • A case of AFP with any of the following set of

HOT CASE • A case of AFP with any of the following set of conditions Ø Age < 5 year plus H/O fever at onset plus asymmetrical proximal paralysis. Ø Age < 5 year with rapidly progressive paralysis leading to bulbar involvement (cranial nerves affected) & death. Ø Any case which in the opinion of SMO/DIO looks like polio. National Polio Surveillance Project: Go. I & WHO

CONTACT SAMPLES To be considered for cases fulfilling criteria like Hot cases, but adequate

CONTACT SAMPLES To be considered for cases fulfilling criteria like Hot cases, but adequate samples from case could not be taken National Polio Surveillance Project: Go. I & WHO

Supplementary Immunization Activities: NIDs/ SNIDs National Polio Surveillance Project: Go. I & WHO

Supplementary Immunization Activities: NIDs/ SNIDs National Polio Surveillance Project: Go. I & WHO

SIAs National Immunization Day. • NID: - Booth Activity. - House-to house Activity. -

SIAs National Immunization Day. • NID: - Booth Activity. - House-to house Activity. - Transit Teams. - Mobile Teams. • SNID: Sub National Immunization Day. - Migratory SNID in Gujarat (11 districts & 5 corporations). National Polio Surveillance Project: Go. I & WHO

Continued focus on high risk areas and populations 107 blocks of UP and Bihar

Continued focus on high risk areas and populations 107 blocks of UP and Bihar West UP: HR blocks – 66 Kosi river operational intensification Immunization of newborns Bihar: HR blocks – 41 Intense focus on migrants & mobile populations Religious congregations 2 million children vaccinated in congregations each year 8 million children in transit immunized in India each round 100, 000 of these in running trains National Polio Surveillance Project: Go. I & WHO

Certification of polio eradication National Polio Surveillance Project: Go. I & WHO

Certification of polio eradication National Polio Surveillance Project: Go. I & WHO

Background • Certification is done for WHO Regions; not for individual countries • WHO

Background • Certification is done for WHO Regions; not for individual countries • WHO Regions certified polio free: – Americas 1994 – Western Pacific 2000 – Europe 2002 • Certification of a region is considered only when – All countries in the area demonstrate ØAbsence of WPV transmission for at least 3 consecutive years ØPresence of certification standard surveillance ØGlobal action plan for laboratory containment of WPV National Polio Surveillance Project: Go. I & WHO

Certification of SEAR* Last WPV case in SEAR 28 Aug: India presents Preliminary Document

Certification of SEAR* Last WPV case in SEAR 28 Aug: India presents Preliminary Document Dec: Special RCC Meeting for India GCC formed SEARCCPE formed 1995 1997 * South 2 RCCPE meetings planned 2011 2012 Feb: India will present final document Certification of SEAR likely 2013 2014 East Asia Region of WHO National Polio Surveillance Project: Go. I & WHO

Certification standard surveillance • Non-polio AFP rate: ≥ 2 per 100, 000 population (<

Certification standard surveillance • Non-polio AFP rate: ≥ 2 per 100, 000 population (< 15 years) annually • Adequate stool specimens : ≥ 80% • All stool specimens tested for poliovirus at WHO -accredited laboratory • Additional Criteria • Investigation of AFP cases within 48 hours of initial notification: ≥ 80% • Timeliness of weekly AFP surveillance reports: ≥ 80% National Polio Surveillance Project: Go. I & WHO

National Certification Committee for Poliomyelitis Eradication (NCCPE) • Established in 1998 to • Examine,

National Certification Committee for Poliomyelitis Eradication (NCCPE) • Established in 1998 to • Examine, assess & verify data collected by govt. • Field visits to review evidence of interruption of poliovirus transmission in the country • Independent judgment of polio status • Present country report to RCCPE* Regional Certification Commission for Poliomyelitis Eradication * National Polio Surveillance Project: Go. I & WHO

NCCPE Field Visits • Sep 12 - Jun 13 • Five categories of states

NCCPE Field Visits • Sep 12 - Jun 13 • Five categories of states have been formed Category 5 states National Polio Surveillance Project: Go. I & WHO

Laboratory Containment • Union Health Ministry already issued letter in this regard to all

Laboratory Containment • Union Health Ministry already issued letter in this regard to all the States (dated 14 th Feb 2013). • National Task Force for Lab Containment of WPV formed, Health Secretary (GOI) Chairman. • To identify Labs, likely to store WPV – by Dec 2013. National Polio Surveillance Project: Go. I & WHO

Polio Endgame Strategy National Polio Surveillance Project: Go. I & WHO

Polio Endgame Strategy National Polio Surveillance Project: Go. I & WHO

Context • No WPV 2 in India since 1999 • t. OPV used in

Context • No WPV 2 in India since 1999 • t. OPV used in RI and during NIDs • b. OPV used in most SNIDs since Jan 2010 • Areas/ populations with low routine immunization coverage • All c. VDPVs in India due to type 2 in setting of low immunity to type 2 National Polio Surveillance Project: Go. I & WHO

c. VDPV cases, India 2009 -2011 • c. VDPV cases detected in 2009 -10

c. VDPV cases, India 2009 -2011 • c. VDPV cases detected in 2009 -10 • 100% due to type 2 District Type 2 2009 2010 2011 Badaun 3 0 0 Bulandshah ar 2 0 0 Ghaziabad 0 1 0 Meerut 2 0 0 Moradabad 2 0 0 Pilibhit 4 0 0 Shahjahanp ur 2 1 0 Total 15 2 0 National Polio Surveillance Project: Go. I & WHO

Trends in Seroprevalence Against Poliovirus Results from Different Serosurveys Moradabad Nov 2007 (N=121) AFP

Trends in Seroprevalence Against Poliovirus Results from Different Serosurveys Moradabad Nov 2007 (N=121) AFP cases UP Nov 08 – mid 09 (169) Moradabad May 2009 (N=534) UP & Bihar Aug 2010 (N=1280) UP & Bihar Aug 2011 (N=1246) 6 -7 mo 6 -11 mo Type 1 78% 96. 5% 99% 98. 5% Type 2 56% 33. 7% 75% 65% 85% Type 3 69% 42. 6% 49% 77% 88. 2% Age High immunity levels sustained for P 1 since 2009 Increasing trend in immunity level for P 3 in 2010 -11 National Polio Surveillance Project: Go. I & WHO

Managing the risk of VDPVs National Polio Surveillance Project: Go. I & WHO

Managing the risk of VDPVs National Polio Surveillance Project: Go. I & WHO

Preparing for the polio endgame • A t. OPV- b. OPV switch globally (~2014/2015)

Preparing for the polio endgame • A t. OPV- b. OPV switch globally (~2014/2015) • Use of IPV in conjunction with OPV (? ) • Eventual cessation of all OPV use globally at some point in the future (e. g. 2017 -18 period). • Support research activities to generate evidence to guide decision making National Polio Surveillance Project: Go. I & WHO

Pre-switch boosting of type 2 immunity • Switch soon after t. OPV NIDs •

Pre-switch boosting of type 2 immunity • Switch soon after t. OPV NIDs • Improve RI, particularly DTP 3 and OPV 3 coverage • Adding a dose of IPV in RI for infants prior to switch National Polio Surveillance Project: Go. I & WHO

Conclusions • India can be in a position to move ahead with polio endgame

Conclusions • India can be in a position to move ahead with polio endgame strategy • Careful planning and consideration of risks required before implementation • Earliest possible timing for t. OPV-b. OPV switch: Qtr. 1 2014 • Lessons from t. OPV-b. OPV switch significant for subsequent withdrawal of all OPV from programme National Polio Surveillance Project: Go. I & WHO

Thank you National Polio Surveillance Project: Go. I & WHO

Thank you National Polio Surveillance Project: Go. I & WHO